|
PRLD Prelude Therapeutics Inc 1678660 |
| Balance Sheet |
|
Current Assets
|
156,387,000 |
|
Assets
|
197,220,000 |
|
Current Liabilities
|
22,224,000 |
|
Liabilities
|
40,789,000 |
|
Equity
|
156,431,000 |
|
Shares Out
|
42,174,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-82,144,000 |
|
Investing Cash Flow
|
68,073,000 |
| Market Analysis |
Market Cap
|
137,561,175 |
|
Price
|
1.05 |
|
BVPS
|
3.71 |
|
PB
|
0.28 |
|
EPS
|
-1.80 |
|
PS
|
10.14 |
|
FCF
|
-14,071,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PRLD documents filed with the SEC.
PRLD Filings
Clear
